Indonesia receives 8 million more doses of Sinovac vaccine

On July 22, Indonesia received the 29th batch of COVID-19 vaccine including 8 million doses produced by China's Sinovac.

Indonesia receives 8 million more doses of Sinovac vaccine
Sinovac Biotech's COVID-19 vaccine at a vaccination center in Tijuana, Mexico.

According to a press conference, Indonesian Minister of Religion Yaqut Cholil Qoumas emphasized that receiving this batch of vaccines shows the government's commitment to all Indonesians. Minister Yaqut said the government has set a target of vaccinating 2 million people a day in August and therefore needs to have enough vaccine to provide people.

Mr. Yaqut also called on religious leaders, religious organizations and social sectors to contribute to the success of the national vaccination program. In addition, Minister Yaqut also called on religious believers to pray at home during the implementation of the emergency restriction on community activities (PPKM).

With the receipt of the above batch of vaccines, Indonesia now has more than 180 million doses of COVID-19 vaccine, of which 126 million doses of Sinovac vaccine, 14 million doses of AstraZeneca vaccine, 6 million doses of Sinopharm's vaccine and 4.5 million doses of vaccine. vaccine dose of Moderna.

Indonesia has approved five vaccines for the national immunization program, including Sinovac, AstraZeneca, Pfizer, Moderna and Novavax. In addition, the country also approved four other vaccines for the private vaccination program Gotong Royong (Working Together), including Sinopharm, CanSino, Sputnik V and Anhui Zhifei Longcom.

The Southeast Asian country launched its free national vaccination program on January 13 and the Gotong Royong vaccination program on May 19 with the goal of providing a COVID-19 vaccine to at least 181.5 people. million people aiming to achieve herd immunity by the end of the year.

On the same day, the African Union's special envoy for the COVID-19 pandemic, Strive Masiyiwa said the region will start receiving the first batch of Johnson & Johnson's COVID-19 vaccine, including 400 million doses, next week.

Speaking at an online press conference, Mr. Masiyiwa said this batch of vaccine will be used to inject half of the 800 million people in need of vaccination on the continent. In addition, about 6 million doses of the vaccine will be delivered to the 27 countries in Africa that have already paid for their share of the vaccine, by the end of August, with another 18 countries completing loans from the World Bank ( WB) and other global lending institutions before making payments. Vaccine deliveries will increase by an average of 10 million doses per month, starting in September, increasing to 20 million doses in January 2022 until order completion in September 2022. The remaining missing vaccine will be provided through the COVAX Mechanism or bilateral aid from developed countries like the US.

To date, about 60 million doses of the COVID-19 vaccine have been used in this continent of 1.3 billion people.

Google Tech News

Post a Comment

Previous Post Next Post